Data for: Validity of targeted next generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small cell lung cancer: results of a 2 years experience on 1343 samples

Published: 29 August 2018| Version 1 | DOI: 10.17632/4vmd7bxdct.1
helene blons,
Marc Barritault,
Véronique Giraudet,
Catherine Julie,
William Digan,
Alain Cazier,
Jean Pastre,
Laure Gibault,
Alice Guyard,
Bastien Rance,
Pierre Laurent-Puig,
Elizabeth Fabre,
Stéphane Jouveshomme,
Anne Tallet,
Nicolas Pecuchet,
Véronique Duchatelle,
Françoise Le Pimpec-Barthes,
Antoine Legras,
Etienne Giroux Leprieur


1343 NSCLC patients. Molecular diagnosis, CAST vs NGS. Description of molecular alterations (alterations associations, identifications of new actionable targets) using NGS.



Molecular Biology, Lung Cancer